Stifel reiterated coverage on Precision BioSciences with a new price target

9/10/21 9:30:50 AM ET

Biotechnology: Biological Products (No Diagnostic Substances)

Health Care

Stifel reiterated coverage of Precision BioSciences with a rating of Buy and set a new price target of $26.00 from $23.00 previously

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$DTIL

Date	Price Target	Rating	Analyst
1/10/2025	$34.00	Market Perform → Outperform	BMO Capital Markets
4/30/2024	$19.00	Buy	Guggenheim
6/17/2022	$7.00	Outperform	BMO Capital Markets
6/9/2022		Outperform → Mkt Perform	William Blair
9/10/2021	$23.00 → $26.00	Buy	Stifel